Risks and benefits of omega 3 fats: Summary of responses
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7546.915-b (Published 13 April 2006) Cite this as: BMJ 2006;332:915- Birte Twisselmann, assistant editor (web)
EDITOR—The systematic review by Hooper et al with accompanying editorial by Brunner resulted in 30-odd electronic responses, most of which raised similar concerns.1 2 The main issue was the selection of studies—an “indiscriminate” mix of primary and secondary prevention studies.
The main objection was to the inclusion of the “methodologically poor” DART-2 study,3 which alone changed the conclusion of the meta-analysis from “clear benefit” to “no benefit.” Among the numerous weaknesses that the DART-2 authors themselves had originally drawn attention to, were that this study was …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.